AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2015
Jan 5, 2015
35323_dirs_2015-01-05_a87d0357-7f8a-4915-9852-7783ae5d8516.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-01-02
Reporting Person: HOLLIMAN JOHN M III (Director, Executive Chairman)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-02 | Stock Option (Right to Buy) | $0.22 | A | 50000 | Acquired | 2025-01-02 | Common Stock (50000) | Direct |
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16